CLINICAL_TRIALS
trial_result
· 2016-06-23
Clinical Trial Update: A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]
Summary
Phase I pharmacodynamics study of an oral AR-C165395XX in subjects with Type 2 Diabetes Mellitus. Results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2016-06-23